Insight

Avanish Saklani: Our opinion in Colorectal Disease is worth a read

Photo taken from Avanish Saklani/LinkedIn

Apr 27, 2024, 11:44

Avanish Saklani: Our opinion in Colorectal Disease is worth a read

Avanish Saklani, Professor at TATA MEMORIAL HOSPITAL shared a post on LinkedIn:

“The growing burden of colorectal cancer in developing countries present a challenge. With young onset rectal cancers and an incidence not cost effective to have national screening programme compounded by lack of uniform primary health care result in delayed diagnosis ie locally advanced rectal cancer.

Over the last 3 years, handful of trials have upset the applecart of standard long course chemoradiation followed by Total mesorectal excision (TME) surgery.

These trials have created an opportunity for organ preservation but increased options for Neoadjuvant therapy does create a conundrum, our opinion in Colorectal Disease is worth a read. Thanks to Devesh Ballal and Tejas Vispute, our alumini.

Despite TNT number of patients who recieve beyond TME procedures remains high, Education and early diagnosis remains key to improve outcomes.”

Additional information.
Source: Avanish Saklani/linkedin

Avanish Saklani chemoradiation Colorectal Disease Devesh Ballal OncoDaily Oncology rectal cancers Tata Memorial Hospital Tejas vispute TME Total mesorectal excision Surgery

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage